Russwurm G P, Mackler A M, Fagoaga O R, Brown W S, Sakala E P, Yellon S M, Nehlsen-Cannarella S L
Department of Pathology, Loma Linda University School of Medicine, CA 92350, USA.
Am J Reprod Immunol. 1997 Oct;38(4):256-62. doi: 10.1111/j.1600-0897.1997.tb00512.x.
Soluble human leukocyte antigens (sHLA), interferon-gamma (IFN-gamma), and interleukin-6 (IL-6) were studied during human pregnancy to test the hypothesis that sHLA concentrations are regulated by these specific cytokines.
Enzyme-linked immunoadsorbent assays (ELISA) were used to measure sHLA I and II in maternal circulation, cord blood, and placenta effluents of pregnant and nonpregnant women; maternal serum cytokines were also determined.
sHLA in maternal and cord blood were equivalent to that in the placenta. By the third trimester, sHLA I concentrations in maternal plasma were significantly reduced compared to the first or second trimesters. sHLA II was increased during the second trimester relative to that postpartum. Maternal IL-6 and IFN-gamma concentrations were not statistically different throughout gestation or postpartum.
These data do not suggest a role for maternal plasma IL-6 or IFN-gamma in regulation of systemic sHLA class I during pregnancy, but they do not address whether such events take place in local tissues of the maternal-fetal unit.
在人类妊娠期间研究了可溶性人类白细胞抗原(sHLA)、干扰素-γ(IFN-γ)和白细胞介素-6(IL-6),以检验sHLA浓度受这些特定细胞因子调节的假说。
采用酶联免疫吸附测定(ELISA)法检测孕妇和非孕妇母血循环、脐血及胎盘流出物中的sHLA I和II;同时测定母血清细胞因子。
母血和脐血中的sHLA与胎盘中的相当。妊娠晚期母血浆中sHLA I浓度较妊娠早期或中期显著降低。妊娠中期sHLA II相对于产后升高。整个妊娠期及产后母血IL-6和IFN-γ浓度无统计学差异。
这些数据不提示母血IL-6或IFN-γ在妊娠期间调节全身sHLA I类分子中起作用,但未涉及此类事件是否发生在母胎单位的局部组织中。